|
|
The 3rd Annual Business of Biosimilars is a significant forum in Boston that focuses on the best practices in the fields of biosimilars. It provides a superb platform for leading policy makers, government personnel, investors and ventures capitalists as well as representatives from law firms to discuss growing consumer and physician viewpoints on biosimilars. The conference offers an opportunity to explore the successful strategies to drive scientific, regulatory, economic and legal challenges that industry players face to stay competitive in exploiting their biosimilar portfolio in all over the world. This summit serves as a unique place to build strategic partnerships with international players. The 3rd Annual Business of Biosimilars Conference 2011 will be an ideal forum for assessing scientific implications of biosimilars to assure safety, quality and effectiveness.
Visitor Profile
The targeted visitors at the 3rd Annual Business of Biosimilars Conference 2011 are CEOs, Presidents, VPs, Directors and Managers from the following segments:
- Business Development
- Marketing & Sales
- Regulatory Affairs
- Legal Counsel, IP/Patent Litigation
- Strategic Sourcing
- Scientific Affairs
- Quality Assurance
Organizer
IIR HOLDINGS, LTD-Institute for International Research
